Today, in response to the U.S. Supreme Court recent decision in Dobbs v Jackson Women’s Health Organization, the U.S. Department of Health and Human Services’ Office for Civil Rights (OCR) released guidance for pharmacies that sets forth their obligations under federal civil rights laws, conflicting with some state laws, and raises concerns for our nation's pharmacies and pharmacists.

The Board of Trustees of the American Pharmacists Association announced today that Ilisa Bernstein, PharmD, JD, FAPhA, has been named Interim CEO, effective immediately. Bernstein’s appointment follows the departure of Scott Knoer, PharmD, MS, as Executive Vice-President and CEO.

WASHINGTON, D.C.—CMS has issued a final rule eliminating Part D plans’ and PBMs’ use of retroactive direct and indirect remuneration (DIR) fees beginning on January 1, 2024 (contract year 2024). The American Pharmacists Association (APhA) and many of its members submitted comments to CMS on the proposal. APhA appreciates CMS’ efforts to end the uncertainty and lack of drug cost transparency at the pharmacy caused by retroactive DIR fees.